ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action
- Written by Newsfile
New York, New York--(Newsfile Corp. - June 7, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulcrum Therapeutics Inc. (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusive (the "Class Period"), of the important June 27, 2023 lead plaintiff deadline.
SO WHAT: If you...